ACPE Numbers: 0217-9999-21-018-H01-P
Pre-Sale Date: 06/02/2021
Content Release Date: 06/16/2021
Expiration Dates: 05/10/2022
CE Credits: 1.5 (ACPE and BPS)
Activity Fee: $110 (ASHP member); $160 (non-member)
Accreditation for Pharmacists
The American College of Clinical Pharmacy (ACCP) and the American Society of Health-System Pharmacists (ASHP) are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The target audience for this webinar is the pharmacist interested in learning more about updated information regarding non-small cell lung cancer (NSCLC) targets and for Board-certified Oncology Pharmacists (BCOPs) looking to earn recertification credit.
This course is intended for BCOPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.
This online activity is approved for 1.5 hours of continuing pharmacy education credit and/or recertification credit.
Board certified pharmacists are eligible to receive up to 1.5 hours of recertification credit for completing this webinar. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
This webinar is not intended for those preparing to take the BPS Oncology Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/onc-review.
These activities are part of the ACCP and ASHP professional development program for BCOP recertification approved by the BPS.
For full program information, please visit: http://elearning.ashp.org/catalog/onc-recert
ACCP/ASHP BCOP Webinar Series - Targeting Lung Cancer with a Focus (Cert #L219299)
After participating in this CPE activity, learners should be able to:
- Identify relevant oncogenic targets for patients with non-small cell lung cancer (NSCLC).
- Describe the clinical trials and outcomes of key studies evaluating therapies for the treatment of patients with oncogenic targeted NSCLC.
- Design an appropriate patient-specific treatment and monitoring plan, taking into consideration efficacy and safety outcomes from clinical trials for patients with oncogenic targeted NSCLC.
- Compare various treatment options for patients with oncogenic targeted NSCLC.
Chung-Shien Lee, Pharm.D., BCPS, BCOP
Assistant Professor, St. John’s University
Clinical Pharmacist, Monter Cancer Center
Queens, New York
Alexis Chapman, Pharm.D., BCOP
Nicholas Chow, Pharm.D., BCOP
Minhee Kang, Pharm.D., BCPS, BCOP
Alissa Karr, Pharm.D., BCOP
Erin Kelley, Pharm.D., BCOP
Victoria LaMonaca, Pharm.D., BCOP
Chun Yip LI, MSc. Clin Pharm, BCOP
Pohung Lin, Pharm.D., BCOP, BCPS
Alexander Quesenberry, Pharm.D., BCOP
Forrest Ridgway, Pharm.D., BCPS, BCOP
Carolnn Yong, Pharm.D.. BCPS, BCOP
Abubakr Yousif, B.Pharm. MSC , PG DIP, BCOP
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ACCP and ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
Dr. Chung-Shien Lee has participated on an advisory board for G1 Therapeutics. All planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.
Methods and CE Requirements
This activity consists of audio and slides, a PDF book chapter, an attestation statement, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for the activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
System Technical Requirements
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
These activities were developed by ACCP and ASHP.